De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Dr. Sulaiman Al Habib Medical Services Group Beheer
Beheer criteriumcontroles 3/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Faisal Abdullah Al Nassar
Algemeen directeur
n/a
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | 13.8yrs |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | 5.8yrs |
| Gemiddelde ambtstermijn bestuur | 5.8yrs |
Recente managementupdates
Recent updates
Investors Will Want Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Growth In ROCE To Persist
Jul 04
Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
May 23Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
May 08Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
May 03Subdued Growth No Barrier To Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price
Apr 29There's Been No Shortage Of Growth Recently For Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital
Mar 15Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Dividend Will Be SAR1.15
Feb 22With EPS Growth And More, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Makes An Interesting Case
Feb 20Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price Is Out Of Tune With Earnings
Jan 09We Like These Underlying Return On Capital Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013)
Nov 28We Think That There Are Issues Underlying Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings
Nov 07Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 02Here's Why Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Has Caught The Eye Of Investors
Sep 21Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Doing The Right Things To Multiply Its Share Price
Aug 10Here's Why We Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Well Worth Watching
Jun 17Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
May 12Returns At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Are On The Way Up
May 06Here's Why We Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Mar 13Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital Are Heading Higher
Jan 30With EPS Growth And More, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Makes An Interesting Case
Dec 07Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Doing The Right Things To Multiply Its Share Price
Oct 23If EPS Growth Is Important To You, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Presents An Opportunity
Sep 08Estimating The Intrinsic Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Aug 24Why Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Could Be Worth Watching
Aug 08Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Has More To Do To Multiply In Value Going Forward
Jul 12Does Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Deserve A Spot On Your Watchlist?
May 31A Look At The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
May 17Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Will Pay A Larger Dividend Than Last Year At ر.س0.83
Apr 28Should You Think About Buying Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Now?
Apr 09Return Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Aren't Appealing
Mar 06Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is An Interesting Stock
Feb 16Returns On Capital At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Have Stalled
Dec 05Do Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings Warrant Your Attention?
Nov 17Investors Could Be Concerned With Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital
Aug 30Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Aug 01Estimating The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Jun 11Capital Allocation Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Aren't Ideal
May 27Earnings Beat: Dr. Sulaiman Al Habib Medical Services Group Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 27Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Apr 06A Look At The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Feb 04Is Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Shareholder Ownership Skewed Towards Insiders?
Jan 14
Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Is Yielding 1.5% - But Is It A Buy?
Dec 23Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Nov 27CEO
Faisal Abdullah Al Nassar (44 yo)
13.8yrs
Tenure
ر.س230,000
Compensatie
Mr. Faisal Abdullah Ali Al Nassar serves as a Non-Executive Independent Deputy Chairman of the Board at Al Ramz Real Estate Company. He serves as Group Chief Financial Officer of Dr. Sulaiman Al Habib Medi...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Group Founder & Non-Executive Chairman | 5.8yrs | ر.س215.00k | 40.03% SAR 40.2b | |
| Group CFO | 13.8yrs | ر.س230.00k | geen gegevens | |
| Chief of Business Development & Strategy and Executive Director | no data | ر.س230.00k | 2% SAR 2.0b | |
| Chief Operating Officer | no data | geen gegevens | 0.0095% SAR 9.6m | |
| Group General Counsel & Secretary of the Board | 8.8yrs | geen gegevens | geen gegevens | |
| Chief People Officer | no data | geen gegevens | geen gegevens | |
| Head of Internal Audit Department | 8.8yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Medical Affairs | 2.8yrs | geen gegevens | 0.041% SAR 40.9m | |
| Senior Vice President of Physicians Affairs | 2.7yrs | geen gegevens | geen gegevens | |
| Chief Medical Officer | 2.6yrs | geen gegevens | geen gegevens | |
| General Director of Pharmaceutical Facilities | no data | geen gegevens | geen gegevens | |
| CEO and Member of the Board of Managers of Hulool Al Sahabah for IT & Communication Company | no data | geen gegevens | geen gegevens |
5.8yrs
Gemiddelde duur
Ervaren management: Het managementteam van 4013 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.8 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Group Founder & Non-Executive Chairman | 5.8yrs | ر.س215.00k | 40.03% SAR 40.2b | |
| Group CFO | 5.8yrs | ر.س230.00k | geen gegevens | |
| Chief of Business Development & Strategy and Executive Director | 5.8yrs | ر.س230.00k | 2% SAR 2.0b | |
| CEO and Member of the Board of Managers of Hulool Al Sahabah for IT & Communication Company | no data | geen gegevens | geen gegevens | |
| Independent DIrector | 5.8yrs | ر.س221.00k | 0.0063% SAR 6.4m | |
| Independent Vice Chairman | 5.8yrs | ر.س227.00k | 0.023% SAR 23.1m | |
| Non-Executive Director | 5.8yrs | ر.س187.00k | geen gegevens | |
| Independent Director | no data | ر.س233.00k | 0% SAR 0 | |
| Independent Director | 2.8yrs | ر.س230.00k | geen gegevens |
5.8yrs
Gemiddelde duur
Ervaren bestuur: De raad van bestuur van 4013 wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.8 jaar).